Stem Cell Stocks 5/10/09: The Week That Was

Only individual names in the stem cell sector moved this week. Names like GERN and CCEL have impressive charts over the last month, but we have still yet to see that large group move like earlier in the year. Look for there to be continued sporadic movement in the sector.

Top Stem Cell Stock Performer(s) for Last Week:

- Cytori Therapeutics (CYTX) = Up 37% for the week; They announced an agreement by which GE Healthcare will commercialize Cytori’s StemSource® technology in the North American stem cell banking and research markets.

Worst Stem Cell Stock Performer(s) for Last Week:

- ThermoGenesis Corp (KOOL) = Down -19%; Got hammered for reporting 2009 revenue outlook below analyst estimates.

Stem Cell Stocks Current Price and % Up or Down 5/4/09 - 5/8/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Cur Price: $1.32; Down -11%
Aastrom Biosciences (ASTM) = Cur Price: $0.394; Up 4%
BioTime, Inc. (BTIM) = Cur Price: $1.90; Down -2%
Celgene Corp (CELG) = Cur Price: $41.42; Up 5%
Cytori Therapeutics (CYTX) = Cur Price: $2.50; Up 37%
Geron Corp (GERN) = Cur Price: $6.23; Up 22%
ThermoGenesis (KOOL) = Cur Price: $0.54; Down -19%
Osiris Therapeutics (OSIR) = Cur Price: $13.35; Up 7%
StemCell Inc. (STEM) = Cur Price: $1.70; Up 2%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Cur Price: $0.098; Down -1%
Athersys Inc. (ATHX) = Cur Price: $0.82; Up 1%
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.07; Down -5%
Bioheart Inc. (BHRT) = Cur Price: $0.85; Up 9%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.0057; Up 6%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $1.42; Up 15%
Neuralstem (CUR) = Cur Price: $1.21; Up 5%
International Stem Cell (ISCO.OB) = Cur Price: $0.44; Down -6%
MultiCell Technologies (MCET.OB) = Cur Price: $0.0101; Down -8%
Pluristem Therapeutics (PSTI) = Cur Price: $1.32; Down -13%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.068; Down -9%
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.039; Unchanged

Catalyst(s) for the Week:

- Again, be on the lookout for further legislative movement to support President Obama's executive order.

- M&A (mergers and acquisitions) activity will be key. It could happen at any time.